Recognition of self-antigen-derived epitopes presented by major histocompatibility complex class II (MHC II) molecules on thymic epithelial cells (TECs) is critical for the generation of a functional and self-tolerant CD4 T-cell repertoire. Whereas haematopoietic antigen-presenting cells generate MHC-II-peptide complexes predominantly through the processing of endocytosed polypeptides 1 , it remains unknown if and how TECs use unconventional pathways of antigen presentation. Here we address the role of macroautophagy, a process that has recently been shown to allow for endogenous MHC II loading [2] [3] [4] [5] [6] , in T-cell repertoire selection in the mouse thymus. In contrast to most other tissues, TECs had a high constitutive level of autophagy. Genetic interference with autophagy specifically in TECs led to altered selection of certain MHC-II-restricted T-cell specificities and resulted in severe colitis and multi-organ inflammation. Our findings indicate that autophagy focuses the MHC-II-peptide repertoire of TECs on their intracellular milieu, which notably comprises a wide array of otherwise strictly 'tissue-specific' self antigens 7, 8 . In doing so, it contributes to T-cell selection and is essential for the generation of a self-tolerant T-cell repertoire. Thymic epithelial cells (TECs) are the only non-haematopoietic cell types that constitutively express MHC II. Cortical TECs (cTECs) have predominantly been implicated in positive selection of thymocytes carrying self-MHC-restricted T-cell receptors (TCRs) 9 , whereas medullary TECs (mTECs) fulfil a non-redundant role in tolerance induction by 'promiscuously' expressing otherwise tissue-restricted antigens (TRAs) 7, 8 . Notably, tolerance induction towards mTECderived antigens can operate through direct antigen recognition on mTECs 10 or by cross-presentation by thymic dendritic cells 11 . MHC-II-peptide ligands are primarily generated through processing of exogenous proteins 1 . TECs, however, show a remarkably poor efficacy in capturing and processing extracellular antigens 12 , suggesting alternative pathways of MHC II loading. Candidate routes through which endogenous loading of MHC II molecules may be achieved are a TAP-dependent pathway 13 , chaperone-mediated autophagy 14 and macroautophagy [2] [3] [4] [5] [6] . Macroautophagy is a bulk protein degradation process that is upregulated to sustain metabolic fitness during food deprivation 15 . Autophagosomes fuse with lysosomes for degradation of their cargo, and it is conceivable that at this point an intersection with the MHC II pathway occurs 2 . Because the thymus has been identified as a site of unusual starvation-independent autophagic activity 16 , we hypothesized that this phenomenon may facilitate endogenous MHC II loading in TECs and thus contribute to positive selection and/or tolerance induction.
Using green fluorescent protein (GFP)-LC3 autophagy reporter mice 16 ( Supplementary Fig. 1a ), we confirmed that the thymus had robust, starvation-independent autophagic activity (Fig. 1a ). In contrast, in many other tissues-for example, muscle-detectable autophagy is induced only upon starvation ( Fig. 1a and Supplementary  Fig. 1b) . Absence of punctae in thymi of reporter mice with a targeted disruption of Atg5 (autophagy-related gene 5) 17, 18 , an essential component of autophagosome formation, indicated that these structures were not unspecific aggregates ( Supplementary Fig. 1c ).
When purified thymic stromal cells were analysed (Fig. 1b) , the highest frequency (68. 17 . However, neonatal lethality of Atg5 -/-mice, at least in part caused by a perinatal metabolic crisis, precluded a direct assessment of T-cell selection and tolerance in this system. To assess the capacity of Atg5 -/-thymi to support T-cell development beyond the perinatal phase, we transplanted embryonic Atg5 -/-thymi under the renal capsule of normal adult recipients. When analysed after 6 to 8 weeks, Atg5
-/-thymi were significantly smaller than wild-type controls (Fig. 2a) .
Several observations suggested that the reduced cellularity of Atg5 -/-grafts was not caused by aberrant differentiation of the epithelial compartment. Thus, Atg5
-/-grafts were properly compartmentalized into cortical and medullary areas (Fig. 2b ) and contained cTECs and mTECs at normal frequencies ( Supplementary Fig. 2 ). Expression of MHC I and II on Atg5 -/-epithelial cells was essentially normal; however, a slight decrease in MHC II density was observed on cTECs (Fig. 2c) . Atg5
-/-mTECs showed the typical biphasic MHC II expression indicative of normal segregation into mTEC lo and mTEC hi subsets, and promiscuous antigen expression was intact (Fig. 2d) .
Next we considered whether the reduced cellularity of Atg5 (Fig. 3a) or H-2 b Atg5 -/-thymi ( Supplementary Fig. 3a ). TCR-a or TCR-b V-region use by CD4 single-positive (SP) thymocytes was also normal ( Supplementary  Fig. 3b, c) , indicating that Atg5 -/-deficiency in TECs was compatible with development of a polyclonal T-cell repertoire containing the main T-cell lineages.
Positive selection is remarkably flexible regarding the requirements for the composition of MHC-peptide (MHCp) ligands on cTECs, as exemplified by the efficient selection of polyclonal CD4 T cells in mice expressing a markedly reduced spectrum of MHCp complexes 23, 24 . If autophagy were to contribute to the generation of MHC II ligands on TECs, its absence would be expected to have rather subtle consequences. Two predictions followed from these considerations. First, selection of particular monoclonal MHC-IIrestricted TCR specificities should be affected in Atg5 -/-thymi. Second, if the reduced cellularity of Atg5 -/-thymi was caused by altered T-cell selection, a 'permissive' monoclonal TCR specificity should rescue the organ size. We tested these predictions by analysing the selection of several MHC-II-restricted transgenic TCRs (that is, TCR-HA restricted to I-E (Fig. 3b) . Similarly, Atg5
-/-H-2 b lobes grafted into SEP TCR transgenic hosts had reduced cellularity, and the decreased frequency of CD4 SP cells together with an increased expression of endogenous TCR-a chains indicated that there was selective pressure against this TCR ( Supplementary Fig. 4 ). In contrast, the AND TCR seemed to be selected as efficiently in the Atg5 -/-to AND grafts as in the wild-type to AND controls; this finding coincided with equal cellularities (Fig. 3c ). For the Atg5 -/-to DEP (Supplementary Fig. 5 ) and the Atg5 -/-to DO11.10 ( Supplementary Fig. 6 ) transplants, we likewise observed efficient positive selection of the respective TCR and rescue of thymic cellularities. Of note, the frequency of clonotype-positive CD4 SP cells was significantly increased in the Atg5 -/-to DO11.10 lobes, indicating that Atg5 deficiency could also be beneficial for the selection of particular specificities. Transplantation of Atg5 -/-lobes into mixed (DO11.10 Rag2
-/-) bone marrow chimaeras accentuated the opposing consequences of epithelial Atg5 deficiency for these TCRs ( Supplementary Fig. 6d ). In contrast to these observations with MHC-II-restricted TCRs, selection of three MHC-I-restricted transgenic TCRs (P14 restricted to H-2D b , OT-I restricted to H-2K b and HY restricted to H-2D b ) in Atg5 -/-or wildtype lobes was indistinguishable, both with respect to expression of the transgenic TCR chains and thymic cellularity ( Fig. 3d and Supplementary Fig. 7 ; see also Supplementary Table 1 for a summary). Taken together, these findings were consistent with autophagy in TECs specifically shaping the MHC-II-restricted T-cell repertoire, probably through the generation of particular MHC-IIpeptide ligands. This underscores the notion that distinct pathways of antigen presentation in TECs may be essential for the generation of the 'normal' T-cell repertoire 25, 26 . Evidence that autophagy can indeed mould the composition of MHC II ligands was recently obtained by mass spectrometric analysis of MHC-II-bound peptides of B-lymphoblastoid cell lines in the presence or absence of autophagy 6 . Quantitative considerations rendered such a global assessment of the 'MHC ligandome' impossible for limited numbers of ex vivo isolated TECs. To visualize whether a particular MHC-class-II-bound peptide on cTECs was affected by genetic interference with autophagy, we used a monoclonal antibody (Y-Ae) that recognizes I-A b when occupied by a I-Ea-derived peptide 27 . The I-Ea 52-68 -I-A b complex is abundant on haematopoietic antigen-presenting cells (,10% of all I-A b -peptide complexes) 27 , probably as a result of co-sorting of I-E and I-A molecules. Notably, however, this complex is comparatively underrepresented on cTECs, and it was hypothesized that this was due to competition for I-A b binding by peptides that may be expressed and/or processed in a cTEC-specific manner. When we analysed cTECs from F 1 (BALB/c 3 C57BL/6) Atg5 -/-lobes, we found an increased abundance of the I-Ea 52-68 -I-A b complex as compared to wild-type controls, whereas total MHC II levels showed an inverse behaviour (Fig. 3e, compare with Fig. 2c ). These findings provided direct evidence that Atg5 deficiency causes a quantitative shift in the MHC II ligandome of cTECs. We propose that in Atg5 -/-cTECs, a set of epitopes that rely on autophagy for endogenous MHC II loading may not compete with the Ea peptide, which itself may easily gain access to MHC II by other pathways.
To address whether the T-cell repertoire selected by Atg5 -/-TECs was self-tolerant, Atg5
-/-or Atg5 1/1 thymi were grafted under the kidney capsule of athymic mice (designated nu/nu Atg5-/-or nu/nu WT , respectively). The peripheral repertoire of CD4 T cells was similar with respect to Va and Vb use in both sets of chimaeras ( Supplementary Fig. 8 ). However, the frequency of CD4 T cells with an activated phenotype (CD62L lo and CD69 1 ) was significantly increased in the nu/nu Atg5-/-chimaeras (Fig. 4a) . Between 4 and 6 weeks after grafting, wasting began in nu/nu Atg5-/-but not nu/ nu WT chimaeras, and most of the nu/nu Atg5-/-chimaeras had to be killed between 8 to 16 weeks after grafting (Fig. 4b) . Recipients of Atg5 -/-thymi had patches of flaky skin, and inspection of internal organs showed a massively enlarged colon, atrophy of the uterus, complete absence of fat pads and in many cases enlarged lymph nodes (Fig. 4c) . Histological examination demonstrated inflammatory infiltrates in the colon, liver, lung, uterus and Harderian gland ( Fig. 4d and Supplementary Table 2 ). Chimaeras generated with 5 days deoxyguanosine treatment of embryonic lobes or by transplantation immediately after preparation yielded essentially identical outcomes, excluding organ-culture-related epithelial tissue damage or carry-over of Atg5 -/-haematopoietic cells as critical factors for disease development. The latter point was bolstered by the fact that Atg5 -/-to wild-type fetal liver chimaeras did not show any signs of autoimmunity (Supplementary Fig. 9; ref. 28 ).
Adoptive transfer of 1 3 10 7 purified CD90 1 T cells from nu/ nu Atg5-/-chimaeras into nu/nu recipients recapitulated essentially all aspects of autoimmunity as observed in donor chimaeras ( Supplementary Fig. 10 ). When transferred separately, CD4
1 T cells from nu/nu Atg5-/-chimaeras elicited autoimmune symptoms more efficiently than CD8
1 T cells, in line with Atg5 -/-deficiency in thymic epithelium primarily perturbing the selection of the CD4 T-cell repertoire (data not shown).
Taken together, we propose that perturbations in both positive and negative selection caused by Atg5 deficiency in TECs may synergize to fuel autoimmunity. First, alterations in the composition of MHCp ligands on cTECs may affect positive selection, potentially creating a mildly lymphopenic environment that might foster autoimmunity. Second, impaired presentation of TRAs by mTECs may allow for exit into the periphery of autoreactive thymocytes that would normally be deleted or deviated into the regulatory T cell lineage. The organ selectivity of the autoimmune manifestations observed here remains to be explained. Of note, the Harderian gland itself has a substantial level of constitutive autophagy ( Supplementary Fig. 11 ). Thus, autophagy-dependent epitope display in the periphery, if not counterbalanced by an analogous tolerogenic mechanism in the thymus, may be critical for immune-mediated tissue destruction. Along these lines, the human ATG16L1 gene was recently identified as a susceptibility locus for Crohn's disease 29, 30 . Our data offer an explanation for the association of an autophagy-related gene with breakdown of intestinal immune homeostasis.
METHODS SUMMARY
Animals. All transgenic mouse strains have been described elsewhere. Animal protocols were approved by local authorities. Antibodies and flow cytometry. Flow cytometry was performed according to standard procedures. See full Methods for antibodies. GFP-LC3 analyses. Before analyses, mice were anaesthetized and perfused through the left ventricle with 4% paraformaldehyde. Organs were collected and fixed with sucrose. Tissue samples were embedded in optimal cutting temperature (OCT) medium and sectioned at 5 mm before staining with an anti-GFP antibody. For quantification, purified thymic stromal cells were obtained from enzymatically digested thymi by a combination of density fractionation and FACS sorting. Stromal cells were fixed onto slides and processed for staining with an anti-GFP antibody. Thymus transplantation. Embryonic thymi were transplanted under the kidney capsule of female animals. Atg5 -/-embryos and Atg5 1/1 (wild-type) controls within individual experiments were obtained from the same Atg5 1/-pregnant female. Histopathology. Organs were immersion-fixed and embedded in paraffin blocks. Sections were stained with haematoxylin and eosin and automatically scanned using the Zeiss MIRAX SCAN system. Statistical analyses. All statistical analyses were performed using the two-tailed Student's t-test with unequal variance.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature. 
METHODS
Animals. Atg5 -/-and GFP-LC3 mice have been described previously 17, 16 . BALB/ c nu/nu animals were purchased from Taconic Farms. The AND TCR transgenic and B10.A animals were obtained from Jackson Laboratories. The TCR-HA, DO11.10, SEP and DEP TCR transgenic animals were described elsewhere 31, 32 . All mice were bred and maintained in individually ventilated cages in the animal facility of the Research Institute of Molecular Pathology under specific pathogen-free conditions. All animal studies were approved by local authorities (MA58) and were performed according to Austrian regulations. Antibodies and flow cytometry. Biotin-conjugated monoclonal antibody Y-Ae was a gift from B. Kyewski. The following monoclonal antibodies were used: biotin-conjugated antibody to CD11c (HL3), CD62L (MEL14), CD80 (16-10A1), Vb3 (KJ25) and Vb14 (14-2); fluorescein isothiocyanate (FITC)-conjugated antibody to CD62L (MEL14), CD90.1 (HIS51), H-2K b (AF6-88.5), Va8.3 (KT50), Vb3 (KJ25), Vb4 (KT4), Vb5.1,5.2 (MR9-4), Vb6 (RR4-7), Vb8.1/2 (MR5-2), Vb8.3 (1B3.3) and Vb13 (MR12-3) ; phycoerythrin-conjugated antibody to CD69 (H1.2F3), Ly51 (BP-1), Va2 (B20.1), Va11.1,11.2 (RR8-1), Vb2 (B20.6), Vb7 (TR310), Vb8.3 (1B3.3) and Vb10 (B21.5); CyChrome-conjugated antibody to CD8 (53-6.7) and CD45 (30-F11) ; phycoerythrin-Cy7 conjugated antibody to CD25 (PC61); allophycocyanin-conjugated antibody to CD4 (RM4-5) and CD8 (52-6.7); allophycocyanin-indotricarbocyanin-conjugated antibody to CD4 (GK1.5); and phycoerythin-Cy7-conjugated streptavidin and FITC-conjugated streptavidin (Becton Dickinson). Phycoerythrin-conjugated monoclonal antibody to TCR-HYa (T3.70) was purchased from eBiosciences. Ulex europaeus agglutinin (UEA-1) was purchased from Sigma Aldrich and conjugated to Alexa 647 in our laboratory. Monoclonal antibodies specific for TCR-HA (6.5), DO11.10 (KJ1-26), EpCAM (G8.8), Vb8 (F23.1), pan-MHC class II (P7.7) and CD4 (GK1.5) were purified from hybridoma supernatants and conjugated to biotin, Alexa Fluor 488 or Alexa Fluor 647 in our laboratory. Surface staining was performed according to standard procedures at a density of 1 3 10 6 to 3 3 10 6 cells per 50 ml. FoxP3 intracellular staining was carried out according to the manufacturer's recommendations with phycoerythrin-or allophycocyanin-conjugated monoclonal antibodies to mouse FoxP3 (FJK-16s, eBiosciences). A FACSCanto (Becton Dickinson) with FACSDiva software (Becton Dickinson) was used for data acquisition and the Flow Jo software was used for data analysis. Immunofluorescence. Frozen sections (5 mm) were fixed in cold acetone, and then washed and blocked for 30 min with 10% (v/v) FCS in PBS. Sections were permeabilized in 0.1% (v/v) Tween in PBS for 10 min, and stained overnight at 4 uC with biotinylated anti-keratin 8 antibody (TROMA-1, Developmental Studies Hybridoma Bank). Sections were incubated with secondary antibody for 90 min at room temperature and, after washing three times for 15 min each in 0.1% (v/v) Tween in PBS, were blocked with anti-rat serum (Jackson Immuno Research Laboratories) for 30 min at room temperature. After washing, sections were incubated with anti-keratin 5 antibody (Covance) for 2 h at room temperature. Secondary reagents were streptavidin-Cy3 (Jackson Immuno Research Laboratories) and Alexa-Fluor-488-conjugated anti-rabbit antibody (Molecular Probes). Nuclei were counterstained with ProLong Gold antifade reagent with DAPI (Molecular Probes). Samples were analysed with an inverted confocal LSM 510 laser scanning confocal microscope (Zeiss). GFP-LC3 analyses. GFP-LC3 mice and wild-type controls were maintained on a normal diet or kept without food for 48 h before analyses, with free access to drinking water. Before analyses, mice were anaesthetized and perfused through the left ventricle with 4% paraformaldehyde in PBS. Organs were collected and further fixed with the same fixative for 4 h, followed by treatment with 15% sucrose in PBS for 4 h at room temperature and then with 30% sucrose solution overnight at 4 uC. Tissue samples were embedded in OCT (Sakura Finetek Europe B.V.) and stored at 270 uC. The samples were sectioned (5 mm), and stained with Alexa-Fluor-488-conjugated anti-GFP antibody (Molecular Probes) overnight at 4 uC. Samples were mounted using ProLong Gold antifade reagent with DAPI. Quantification of autophagic activity in thymic stromal cells. Thymi from two-week-old GFP-LC3 mice were cut into small pieces and digested at 37 uC in IMDM containing 0.2 mg ml 21 collagenase (Roche), 0.2 mg ml 21 dispase I (Roche), 2% FCS, 25 mM HEPES (pH 7.2) and 25 mg ml 21 DNase I, followed by incubation in 5 mM EDTA for 5 min. Cells were washed and resuspended in Percoll (GE Healthcare), followed by a layer of Percoll and PBS as the upper phase. Gradients were spun for 30 min at 1,350g in the cold, and low density cells were collected from the upper interface, washed and then stained for FACS sorting. Stromal cells were sorted according to CD45, Ly51, EpCAM, CD80 
CD11c
1 ) and fixed on to poly-L-lysine-coated slides (Sigma Aldrich) with ice cold acetone. Cells were permeabilized in 0.1% (v/v) Tween in PBS for 10 min, and blocked with 10% (v/v) FCS in PBS for 30 min at room temperature. Cells were incubated overnight at 4 uC with Alexa-Fluor-488-conjugated anti-GFP antibody and mounted with ProLong Gold antifade reagent with DAPI. A total of 1,000 dendritic cells, 1,845 cTECs, 1,232 mTEC hi and 245 mTEC lo have been analysed for determination of the percentage of autophagypositive cells. Cells with more than five autophagosomes (that is, GFP-positive punctae between 0.5 and 1.5 mm in diameter) were scored as positive. For quantification of the number of autophagosomes per cell, a total of 81 autophagypositive cTECs and 51 autophagy positive mTEC hi have been recorded and analysed. Cells were analysed with an inverted confocal LSM510 Zeiss microscope by taking Z stacks of 0.5 mm thickness and subsequently the number of autophagosomes in the whole cell was determined. Purification and adoptive transfer of T cells. Pooled cell suspensions of spleen and lymph nodes (mesenteric, inguinal, axillary, brachial, superficial cervical, deep cervical and lumbar) from nu/nu Atg52/2 and nu/nu WT chimaeras were subjected to erythrocyte lysis. Cells were then incubated with Fc-receptor-blocking antibody (2.4G2) and were stained with biotin-anti-CD90.2 (30-H-12) . After incubation with streptavidin microbeads (Miltenyi Biotec), CD90
1 cells were positively selected on midi-MACS columns. 1 3 10 7 CD90 1 cells were injected in a volume of 200 ml in PBS into the lateral tail veins of BALB/c nu/nu animals. Animals were analysed 6-12 weeks after transfer. Thymus transplantation. Embryonic thymi (E15; with or without deoxyguanosine treatment) were transplanted under the kidney capsule of female animals.
Atg5
-/-embryos and Atg5 1/1 (wild type) controls in individual experiments were obtained from the same Atg5
